FDA adds staff under expansion

Share this article:
New FDA plan to monitor drug safety
New FDA plan to monitor drug safety
The FDA plans to hire an additional 1,300 scientists and pharmacologists as part of an expansion of its drug approval and safety operations processes.

The 1,300 new hires will add to the agency's current staff of about 10,000 employees and would nearly be triple the number of people hired by the FDA from 2005-2007, according to published reports.
Increased user fees are expected to pay for 700 of the new additions. 

The additional positions are driven by the FDA Amendments Act of 2007 and the Import Safety Plan.
“It takes a large pool of talented people for the FDA to protect and promote the public health,” said FDA deputy commissioner for operations John Dyer in a statement. 

The FDA will hold job fairs across the country as part of its hiring process, the agency said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...